Report cover image

Cancer Immunotherapy Market, By Therapy Type (Monoclonal Antibodies, Cancer Vaccines, Immunomodulators, Immune Check Point Inhibitors, and Other Therapy Types), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Lung Cancer, and Other Applicatio

Publisher Coherent Market Insights
Published Oct 10, 2022
Length 168 Pages
SKU # CMI17490101

Description

Cancer Immunotherapy Market, By Therapy Type (Monoclonal Antibodies, Cancer Vaccines, Immunomodulators, Immune Check Point Inhibitors, and Other Therapy Types), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Lung Cancer, and Other Applications), By End Users (Hospitals and Clinics, Cancer Research Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Immunotherapy enables the immune system to recognize and target cancer cells, making it a universal answer to cancer. Immunotherapy is a type of cancer treatment that helps the body’s immune system fight cancer. Cancer immunotherapy work on many different types of cancer. Immunotherapy help improve outcomes for people with several types of cancer that typically have a poor diagnosis. In some cases, such as lung cancer and melanoma skin cancer, cancer immunotherapy has been successful at treating even advanced cancers.

Market Dynamics:

Increase in incidence/prevalence of cancer, increase in awareness among people about cancer, immunotherapy, rise in effectivity and accuracy of newer therapies, and increase in research and development activities are major factors expected to boost the growth of the global cancer immunotherapy market during the forecast period.

For instance, in May 2022, UVA Health and Charlottesville-based Focused Ultrasound Center announced the launch of the Focused Ultrasound Cancer Immunotherapy Center, the world’s first center dedicated specifically to advancing a focused ultrasound and cancer immunotherapy treatment approach that could revolutionize 21st-century cancer care.

Moreover, in May 2021, Astellas Pharma announced the approval of the XTANDI therapy (enzalutamide) by the European Commission. XTANDI is the only available approved oral treatment for three kinds of prostate cancer, including non-metastatic, metastatic hormone sensitive, and metastatic castration resistant.

Key features of the study:
  • This report provides in-depth analysis of the global cancer immunotherapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • This report profiles key players in the global cancer immunotherapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Novartis AG, Merck & Co. Inc., F-Hoffmann La Roche, Eli Lilly and Company, Bayer AG, AstraZeneca, Astellas Pharma Inc., Amgen Inc., OSE Immunotherapeutics SA, and Bristol- Myers Squibb Company among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cancer immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer immunotherapy market.
Detailed Segmentation:
  • Global Cancer Immunotherapy Market, By Therapy Type:
  • Monoclonal Antibodies
  • Cancer Vaccines
  • Immunomodulators
  • Immune Check Point Inhibitors
  • Other Therapy Types
  • Global Cancer Immunotherapy Market, By Application:
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer
  • Lung Cancer
  • Other Applications
  • Global Cancer Immunotherapy Market, By End Users:
  • Hospitals and Clinics
  • Cancer Research Centers
  • Other End Users
  • Global Cancer Immunotherapy Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
  • Company Profiles:
  • Novartis AG
  • Merck & Co. Inc.
  • F-Hoffmann La Roche
  • Eli Lilly and Company
  • Bayer AG
  • AstraZeneca
  • Astellas Pharma Inc.
  • Amgen Inc.
  • OSE Immunotherapeutics SA
  • Bristol- Myers Squibb Company

Table of Contents

168 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Therapy Type
Market Snapshot, By Application
Market Snapshot, By End Users
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increase in prevalence of cancer around the world
High cost of cancer immunotherapy treatment
Rise in research and development (R&D) activities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Cancer Immunotherapy Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Cancer Immunotherapy Market, By Therapy Type, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Cancer Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Immunomodulators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Immune Check Point Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Other Therapy Types
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Cancer Immunotherapy Market, By Application, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Skin Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Global Cancer Immunotherapy Market, By End Users, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Cancer Research Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
Other End Users
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
8. Global Cancer Immunotherapy Market, By Geography, 2017-2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 – 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Middle East and Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
Rest of World
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
9. Competitive Landscape
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co. Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
F-Hoffmann La Roche
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Astellas Pharma Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
OSE Immunotherapeutics SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol- Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Cancer Immunotherapy Market” - forecast to 2028

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us